Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized Controlled Trial for Repetitive Deliberate Self-harm and Suicidal Behaviours Among Norwegian Adolescents: a Comparison Between Dialectical Behaviour Therapy Adapted for Adolescents (DBT-A) and Enhanced Usual Care (EUC)
Brief Summary: The purpose of the study is to evaluate the efficiency of dialectical behavior therapy (DBT) in treatment of adolescents with deliberate self harm compared to Enhanced Usual Care (EUC). Eighty patients in the age of 12-18 yrs old will be included in the study. The main inclusion criterion is repetitive deliberate self-harm. The patients will receive 16 weeks treatment in outpatient clinics in Oslo, after having been randomized to DBT or EUC. They will be assessed on five different time-points: baseline (before starting treatment), 6 weeks (after start of treatment), 12 weeks, 16 weeks and 68 weeks.

The main study hypothesis is:

* DBT will be significantly more effective in treatment of self-harm behavior, as measured/indicated by reduction in number of self-harm episodes with or without intent to die, as well as reduction of number of emergency room visits.
* It is also hypothesized that DBT will significantly reduce the level of suicidal ideation and depressive symptoms compared to EUC.


Options:
A: Arm Label: Group 1; Type: EXPERIMENTAL; Interventions: Device: Active tDCS, Device: Sham tDCS | Arm Label: Group 2; Type: EXPERIMENTAL; Interventions: Device: Active tDCS, Device: Sham tDCS | Intervention Type: DEVICE; Name: Active tDCS; Assigned to Arm(s): Group 1, Group 2 | Intervention Type: DEVICE; Name: Sham tDCS; Assigned to Arm(s): Group 1, Group 2
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Dialectical behavioral therapy for adolescents (DBT-A) | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Treatment as usual | Intervention Type: BEHAVIORAL; Name: Dialectical behavioral therapy for adolescents (DBT-A); Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Treatment as usual; Assigned to Arm(s): 2
C: Arm Label: STEPPS; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Systems Training for Emotional Predictability and Problem Solving (STEPPS) | Arm Label: Treatment as Usual; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Treatment As Usual (TAU) | Intervention Type: BEHAVIORAL; Name: Systems Training for Emotional Predictability and Problem Solving (STEPPS); Assigned to Arm(s): STEPPS | Intervention Type: BEHAVIORAL; Name: Treatment As Usual (TAU); Assigned to Arm(s): Treatment as Usual
D: Arm Label: BI 1358894 5mg; Type: EXPERIMENTAL; Interventions: Drug: BI 1358894 | Arm Label: BI 1358894 25mg; Type: EXPERIMENTAL; Interventions: Drug: BI 1358894 | Arm Label: BI 1358894 75mg; Type: EXPERIMENTAL; Interventions: Drug: BI 1358894 | Arm Label: BI 1358894 125mg; Type: EXPERIMENTAL; Interventions: Drug: BI 1358894 | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: BI 1358894; Assigned to Arm(s): BI 1358894 125mg, BI 1358894 25mg, BI 1358894 5mg, BI 1358894 75mg | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo

Answer: B